Updated Definity Optison Warning
FDA Updates About Definity And Optison Warning. Healthcare providers were notified today about labeling changes for Definity and Optison, micro-bubble contrast agents used in sonograms of the heart. The revised Boxed Warning and Warnings continue to highlight the risk of serious cardiopulmonary reactions during or within 30 minutes … [Read more...] about Updated Definity Optison Warning
FDA Concern on Definity and Optison Side Effects
Definity and Optison Side Effects. Definity and Optison - micro-bubble contrast agents used in sonograms of the heart - are still endangering patients. According to documents released Friday by the Food & Drug Administration (FDA), four more deaths have been linked to Definity since last fall, and the agency says it … [Read more...] about FDA Concern on Definity and Optison Side Effects
Revised Definity, Optison Black Box Warning
Optison Black Box Warning Revised. The Food & Drug Administration (FDA) is watering down its warning about the possible risks of Definity and Optison, micro-bubble contrast agents used during ultrasounds of the heart to enhance images during a procedure called echocardiography. Though the labels of the contrast … [Read more...] about Revised Definity, Optison Black Box Warning
Definity & Optison Contrasting Agents Get Black Box Warnings
Following Reports of Serious Injuries and Deaths.The makers of Definity and Optison, contrasting agents used in ultrasounds of the heart, have agreed to put new black box warnings on the drugs’ package inserts. The Food & Drug Administration (FDA) had asked for the new warnings earlier this month after receiving reports that … [Read more...] about Definity & Optison Contrasting Agents Get Black Box Warnings
